|
 |
| |
| The Company’s intellectual pool of Scientists is constantly engaged in path breaking research. Its focus on drug discovery and advanced drug delivery systems research has resulted in significant progress in its NCE program and development of platform technologies that are being used to develop value-added generic pharmaceuticals. Company’s strong focus on creating intellectual property (IP) assets has resulted in generating revenue streams through IP. |
|
|
